Phase I trial of cetuximab, intensity modulated radiotherapy (IMRT), and ipilimumab in previously untreated, locally advanced head and neck squamous cell carcinoma (PULA HNSCC)

被引：2
|
作者：
Bauman, J. [1 ]
Ferris, R. L. [2 ]
Clump, D. A. [1 ]
Ohr, J. [1 ]
Gooding, W. [1 ]
Kim, S. [2 ]
Karlovits, B. [2 ]
Duvvuri, U. [2 ]
Johnson, J. T. [2 ]
Petro, D. [1 ]
Heron, D. [1 ]
机构：
[1] UPMC, Hillman Canc Ctr, UPCI, Pittsburgh, PA USA
[2] Univ Pittsburgh, Inst Eye & Ear, Dept Otolaryngol, Div Head & Neck Surg, Pittsburgh, PA 15213 USA
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
10.1093/annonc/mdw435.31
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LBA36
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Radiobiological Evaluation of Intensity Modulated Radiotherapy Treatment for Locally Advanced Head and Neck Squamous Cell Carcinomas
    Reddy, B. Rekha
    Ravikumar, M.
    Pasha, C. R. Tanvir
    Kumar, M. R. Anil
    Pyakuryal, A.
    Varatharaj, C.
    Narayanasamy, Ganesh
    MEDICAL PHYSICS, 2014, 41 (06) : 287 - 287
  • [22] Comparison of Volumetric Modulated Arc Therapy (VMAT) and Conventional Intensity-Modulated Radiotherapy (IMRT) for Locally Advanced Head and Neck Squamous Cell Carcinoma: A Retrospective Cohort Study
    Algouneh, Arash
    Schneider, Ken
    Huang, Kitty
    Hussein, Abdulkadir
    Pan, Ming
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (05)
  • [23] Radiotherapy for the management of locally advanced squamous cell carcinoma of the head and neck
    Ko, C.
    Citrin, D.
    ORAL DISEASES, 2009, 15 (02) : 121 - 132
  • [24] Radiotherapy and chemotherapy in locally advanced head and neck squamous cell carcinoma
    Krstevska, V.
    JOURNAL OF BUON, 2009, 14 (03): : 361 - 373
  • [25] A Phase 1 Trial of Pazopanib Added to Cetuximab in Patients With Incurable Head and Neck Squamous Cell Carcinoma (HNSCC)
    Adkins, D.
    Ley, J.
    Wildes, T.
    Trinkaus, K.
    Siegel, M.
    Michel, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 94 (04): : 868 - 868
  • [26] Efficacy of intensity-modulated radiotherapy combined with chemotherapy or surgery in locally advanced squamous cell carcinoma of the head-and-neck
    Yang, Hua
    Diao, Li-Qiong
    Shi, Mei
    Ma, Rui
    Wang, Jian-Hua
    Li, Jian-Ping
    Xiao, Feng
    Xue, Ying
    Xu, Man
    Zhou, Bin
    BIOLOGICS-TARGETS & THERAPY, 2013, 7 : 223 - 228
  • [27] Randomized phase II trial of ficlatuzumab with or without cetuximab in pan-refractory, advanced head and neck squamous cell carcinoma (HNSCC).
    Bauman, Julie E.
    Saba, Nabil F.
    Roe, Denise
    Bauman, Jessica R.
    Kaczmar, John M.
    Bhatia, Aarti K.
    Muzaffar, Jameel
    Julian, Ricklie Ann
    Wang, Steven
    Bearelly, Shethal
    Baker, Audrey
    Steuer, Conor Ernst
    Giri, Anshu
    Burtness, Barbara
    Centuori, Sara
    Caulin, Carlos
    Saboda, Kathylynn
    Obara, Stefanie
    Chung, Christine H.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [28] Phase I study of cetuximab, intensity-modulated radiotherapy (C-IMRT), and intratumoral EGFR antisense (AS) DNA in patients with locally advanced head and neck cancer (HNC)
    Bauman, Julie E.
    Duvvuri, Umamaheswar
    Gooding, William E.
    Clump, David Andrew
    Karlovits, Brian J.
    Wehbe, Ahmad Mouhamad
    Miller, Frank R.
    Johnson, Jonas Talmadge
    Ferris, Robert L.
    Kim, Seungwon
    Heron, Dwight Earl
    Ohr, James
    Grandis, Jennifer R.
    Argiris, Athanassios
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [29] A phase I/II dose escalation study of the CDK4/6 inhibitor, palbociclib in combination with cetuximab and intensity modulated radiation therapy (IMRT) for locally advanced squamous cell carcinoma of the head and neck (SCCHN)
    Ngamphaiboon, N.
    Lukerak, S.
    Jiarpinitnun, C.
    Jinawath, A.
    Jinawath, N.
    Juengsamarn, J.
    Arsa, L.
    Konmun, J.
    Kongsuphon, N.
    Sankaseam, N.
    Sirachainan, E.
    Witoonpanich, P.
    Kositwattanarerk, A.
    Pattaranutaporn, P.
    ANNALS OF ONCOLOGY, 2018, 29
  • [30] A phase 1 trial of NBTXR3 nanoparticles activated by intensity-modulated radiation therapy (IMRT) in the treatment of advanced-stage head and neck squamous cell carcinoma (HNSCC).
    Le Tourneau, Christophe
    Calugaru, Valentin
    Jouffroy, Thomas
    Rodriguez, Jose
    Hoffmann, Caroline
    Dodger, Bernard
    Moreno, Victor
    Calvo, Emiliano
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345